Aurora Cannabis has completed a multi-year investment of $3 million in improvements to its manufacturing facility in Pemberton, British Columbia. The site has been renamed to Aurora Alpine.
"Over the last three years, the investments we've made into this facility have resulted in doubling the yield and potency, reaching a record 33.7%," said Alex Miller, executive vice president of Operations and Supply Chain at Aurora. "The name Aurora Alpine reflects our commitment to achieving the highest degree of excellence at a site that's driven by industry-leading genetic technology and backed by a world-class team that make it all possible."
The former Whistler Medical Marijuana Co. site was licensed in 2019 and was built on a legacy of producing award-winning cannabis. The GACP-certified facility enables Aurora to expand its global reach by exporting premium medical cannabis produced from the Aurora Alpine site internationally.
For more information:
Aurora Cannabis Inc.
auroramj.com/